Free Trial
OTCMKTS:RDGL

Vivos (RDGL) Stock Price, News & Analysis

Vivos logo
$0.12 +0.01 (+9.52%)
As of 03:54 PM Eastern

About Vivos Stock (OTCMKTS:RDGL)

Key Stats

Today's Range
$0.11
$0.13
50-Day Range
$0.10
$0.16
52-Week Range
$0.06
$0.26
Volume
684,100 shs
Average Volume
978,001 shs
Market Capitalization
$52.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Vivos Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

RDGL MarketRank™: 

Vivos scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Vivos.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vivos is -11.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vivos is -11.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Vivos' valuation and earnings.
  • Percentage of Shares Shorted

    0.02% of the float of Vivos has been sold short.
  • Short Interest Ratio / Days to Cover

    Vivos has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vivos has recently decreased by 22.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vivos does not currently pay a dividend.

  • Dividend Growth

    Vivos does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.02% of the float of Vivos has been sold short.
  • Short Interest Ratio / Days to Cover

    Vivos has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vivos has recently decreased by 22.67%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vivos this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for RDGL on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vivos insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.50% of the stock of Vivos is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Vivos' insider trading history.
Receive RDGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivos and its competitors with MarketBeat's FREE daily newsletter.

RDGL Stock News Headlines

What President Trump’s Executive Order 14154 means for your money
Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.
See More Headlines

RDGL Stock Analysis - Frequently Asked Questions

Vivos' stock was trading at $0.1149 on January 1st, 2025. Since then, RDGL stock has increased by 0.1% and is now trading at $0.1150.
View the best growth stocks for 2025 here
.

Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivos investors own include MannKind (MNKD), Agenus (AGEN), APA (APA), Aphria (APHA), Bionano Genomics (BNGO), Churchill Capital Corp IV (CCIV) and Canopy Growth (CGC).

Company Calendar

Today
4/24/2025
Next Earnings (Estimated)
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:RDGL
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,890,000.00
Pretax Margin
-12,345.83%

Debt

Sales & Book Value

Annual Sales
$20,000.00
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-5.25

Miscellaneous

Free Float
369,805,000
Market Cap
$47.61 million
Optionable
Not Optionable
Beta
0.88
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:RDGL) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners